Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Clinically Relevant Drug Product Specifications: Methods of Establishment
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Pharmaceutical Equivalents
Drug Product Stability
Biopharmaceutical Factors Influencing Drug Product Design: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 25, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
1Senior Vice President and Chief Clinical Officer, CVS Caremark, Woonsocket, RI, and a Steering Committee Member for the Therapeutic Drug Management, National Quality Forum.
No abstract available in PubMed .
05:46Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
Published on: August 1, 2018
07:00Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
Published on: August 11, 2017